The phosphoinositide 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is the key driver of carcinogenesis and progression in bladder cancer [9]. This evidence concerns the gene AKT1 and urinary bladder carcinoma.